COMP <GO>
CBIO vs DMAC // DIVIDEND YIELD & FCF PAYOUT SAFETY
Crescent Biopharma Inc. (NASDAQ) VS. DiaMedica Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CBIO 2
— DMAC 2
■ METRIC PARITY
LAST: $12.91 (-4.23%) • MKT CAP: $500.7M
dividend-safety
0.00%
LAST: $9.29 (+0.43%) • MKT CAP: $498.8M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CBIO VS. DMAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CBIO | DMAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.86% | -5.67% | -8.19 | DMAC | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 1.40% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.36 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | CBIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.5 | 61.0 | -14.50 | DMAC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $500.7M | $498.8M | $1.9M | CBIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CBIO REV | DMAC REV | CBIO GROSS % | DMAC GROSS % | CBIO FCF | DMAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.8M | $96.3M | — | — | -$72.5M | -$29.1M |
| FY 2024 | $112.1M | $74.7M | — | — | -$31.1M | -$22.1M |
| FY 2023 | $110.0M | $59.5M | — | — | -$34.9M | -$18.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CBIO // BETA —
DMAC // BETA —